MYSM1 and neoplasm: The patients were divided into two groups(a MYSM1-positive group and a MYSM1-negative group) based on the medians of immunohistochemical variable values in diverse cell subsets.MYSM1 expression in tumors was shown to be positively correlated with tumor status (pathological assessment of the primary tumor (pT, P<0.001); regional lymph nodes (pN, P<0.001); distant metastasis (pM, P<0.001), clinic stage (P<0.001) and tumor differentiation grade (P = 0.015).